http://link.springer.com/article/10.1007/s00330-014-3435-z
Clinical indications for computed tomographic colonography: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline
Cristiano Spada & Jaap Stoker & Onofre Alarcon & Federico Barbaro & Davide Bellini & Michael Bretthauer & Margriet C. De Haan & Jean-Marc Dumonceau & Monika Ferlitsch & Steve Halligan & Emma Helbren & Mikael Hellstrom & Ernst J. Kuipers & Philippe Lefere & Thomas Mang & Emanuele Neri & Lucio Petruzziello & Andrew Plumb & Daniele Regge & Stuart A. Taylor & Cesare Hassan & Andrea Laghi
Eur Radiol (2015) 25:331–345
DOI 10.1007/s00330-014-3435-z
"Main recommendations
- ESGE/ESGAR recommend computed tomographic colonography (CTC) as the radiological examination of choice for the diagnosis of colorectal neoplasia. ESGE/ESGAR do not recommend barium enema in this setting (strong recommendation, high quality evidence).
- ESGE/ESGAR recommend CTC, preferably the same or next day, if colonoscopy is incomplete. Delay of CTC should be considered following endoscopic resection. In the case of obstructing colorectal cancer, preoperative contrast-enhanced CTC may also allow location or staging of malignant lesions (strong recommendation, moderate quality evidence).
- When endoscopy is contraindicated or not possible, ESGE/ESGAR recommend CTC as an acceptable and equally sensitive alternative for patients with symptoms suggestive of colorectal cancer (strong recommendation, high quality evidence).
- ESGE/ESGAR recommend referral for endoscopic polypectomy in patients with at least one polyp 6 mm in diameter detected at CTC. CTC surveillance may be clinically considered if patients do not undergo polypectomy (strong recommendation, moderate quality evidence).
- ESGE/ESGAR do not recommend CTC as a primary test for population screening or in individuals with a positive first-degree family history of colorectal cancer (CRC). However, it may be proposed as a CRC screening test on an individual basis providing the screenee is adequately informed about test characteristics, benefits, and risks (weak recommendation, moderate quality evidence)."
No hay comentarios:
Publicar un comentario